Age of Discovery (PharmaTimes, November 2017)

  • 14th November 2017

Five years on from Pfizer selling Discovery Park, the site’s current chief executive Toby Hunter tells PharmaTimes about the plans for its future.

With around 150 companies working in 14 buildings over 440 acres, and several blockbuster drugs to its name, few sites can match Discovery Park’s significance for the UK life science industry

Read the full article in PharmaTimes.



  • Post Categories
  • News